FDA Orange Book · active-ingredient family
Methylphenidate hydrochloride
Methylphenidate hydrochloride is approved as 13 brand and 72 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:RELEXXII · NDA 216117
13
Brand (NDA)
72
Generics (ANDA)
49
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release, for suspension, extended release, solution, tablet, tablet, chewable, tablet, extended release, tablet, extended release, chewable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| RELEXXIIRLD×7 | OSMOTICA PHARM US | NDA 216117 | — | Jun 23, 2022 | |
| ADHANSIA XRRLD×6 | KNOA PHARMA | NDA 212038 | — | Feb 27, 2019 | |
| JORNAY PMRLD×5 | IRONSHORE PHARMS | NDA 209311 | — | Aug 08, 2018 | |
| QUILLICHEW ERRLD×3 | NEXTWAVE PHARMS | NDA 207960 | — | Dec 04, 2015 | |
| APTENSIO XRRLD×7 | RHODES PHARMS | NDA 205831 | AB3 | Apr 17, 2015 | |
| QUILLIVANT XRRLD | NEXTWAVE | NDA 202100 | AB | Sep 27, 2012 | |
| RITALIN LARLD×5 | SANDOZ | NDA 021284 | AB1 | Apr 10, 2004 | |
| METADATE CDRLD×6 | AYTU BIOPHARMA | NDA 021259 | AB2 | May 27, 2003 | |
| METHYLINRLD×3 | SPECGX LLC | NDA 021475 | — | Apr 15, 2003 | |
| METHYLINRLD×2 | SPECGX LLC | NDA 021419 | AA | Dec 19, 2002 | |
| CONCERTARLD×4 | JANSSEN PHARMS | NDA 021121 | AB | Aug 01, 2000 | |
| RITALIN-SRRLD | NOVARTIS | NDA 018029 | — | Mar 30, 1982 | |
| RITALINRLD×3 | SANDOZ | NDA 010187 | AB | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (72)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | SUN PHARM INDS INC | ANDA 217229 | AB | Aug 25, 2023 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | ALKEM LABS LTD | ANDA 214447 | AB | May 23, 2023 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | RHODES PHARMS | ANDA 214111 | — | May 31, 2022 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ASCENT PHARMS INC | ANDA 207417 | AA | Jan 29, 2021 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | CHARTWELL MOLECULAR | ANDA 207414 | — | Dec 16, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ACCORD HLTHCARE | ANDA 213936 | AB | Oct 28, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE | ALKEM LABS LTD | ANDA 212288 | AB | Oct 06, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | SUN PHARM INDS INC | ANDA 205135 | AB | Aug 19, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | GRANULES | ANDA 213473 | AB | Jul 29, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | PRINSTON INC | ANDA 212697 | AB | Jul 23, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | QUAGEN | ANDA 213567 | AA | Jun 04, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ANDA REPOSITORY | ANDA 210764 | AA | Apr 10, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ALKEM LABS LTD | ANDA 211647 | AA | Mar 30, 2020 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ALKEM LABS LTD | ANDA 211779 | AB | Oct 04, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | ASCENT PHARMS INC | ANDA 211009 | AB | Sep 03, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | STRIDES PHARMA INTL | ANDA 204659 | — | Jul 15, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×5 | GRANULES | ANDA 211796 | AB1 | May 23, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | ANDOR PHARMS | ANDA 211918 | AB | Apr 24, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | CEDIPROF INC | ANDA 208737 | AB | Feb 01, 2019 | |
| METHYLPHENIDATE HYDROCHLORIDE×7 | ACTAVIS ELIZABETH | ANDA 208861 | AB3 | Dec 13, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | ALVOGEN | ANDA 210818 | — | Nov 30, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | GRANULES | ANDA 210992 | AB | Nov 21, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | AUROLIFE PHARMA LLC | ANDA 209276 | — | Oct 25, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | HIBROW HLTHCARE | ANDA 210139 | AA | Oct 03, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE | ACTAVIS LABS FL INC | ANDA 206049 | AB | May 17, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ACTAVIS LABS FL | ANDA 076772 | AB | Mar 22, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ACTAVIS LABS FL | ANDA 076655 | AB | Mar 21, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | BIONPHARMA | ANDA 209753 | AB | Mar 02, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE | DR REDDYS LABS SA | ANDA 200886 | AB1 | Feb 26, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | AMNEAL PHARMS | ANDA 207515 | — | Feb 01, 2018 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ASCENT PHARMS INC | ANDA 210354 | AB | Dec 29, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×5 | OSMOTICA PHARM US | ANDA 205327 | AB | Jul 28, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | ANI PHARMS | ANDA 208607 | — | Jul 14, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ABHAI LLC | ANDA 206932 | AB | May 11, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | MPP PHARMA | ANDA 207587 | — | Mar 03, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | QUAGEN | ANDA 204954 | — | Jan 26, 2017 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ABHAI LLC | ANDA 207485 | AA | Nov 18, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | RISING | ANDA 205756 | AB | Nov 07, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | AUROLIFE PHARMA LLC | ANDA 206726 | AB | Oct 21, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ALVOGEN | ANDA 206840 | — | Sep 15, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×6 | IMPAX LABS INC | ANDA 205105 | AB2 | Jul 28, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ALVOGEN | ANDA 204772 | — | Feb 29, 2016 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | NOVEL LABS INC | ANDA 207884 | AB | Nov 13, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×6 | SPECGX LLC | ANDA 203583 | AB2 | Sep 29, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ASCENT PHARMS INC | ANDA 207416 | AB | Sep 22, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | NOVEL LABS INC | ANDA 204602 | AA | Aug 14, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | ABHAI LLC | ANDA 207488 | AB | Jun 09, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | NOVEL LABS INC | ANDA 204115 | — | Feb 25, 2015 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | BARR LABS INC | ANDA 079031 | — | Oct 15, 2014 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | OXFORD PHARMS | ANDA 202892 | AB | Sep 23, 2014 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | MOUNTAIN | ANDA 091159 | — | Mar 12, 2014 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | NOVITIUM PHARMA | ANDA 201466 | — | Nov 12, 2013 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | LANNETT CO INC | ANDA 091695 | BX | Jul 09, 2013 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | SPECGX LLC | ANDA 202608 | BX | Dec 28, 2012 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | TEVA PHARMS | ANDA 077707 | AB2 | Jul 19, 2012 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | TEVA PHARMS | ANDA 078873 | — | Jul 19, 2012 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | SUN PHARM INDS INC | ANDA 090710 | AB | Mar 15, 2012 | |
| METHYLPHENIDATE HYDROCHLORIDE×4 | DR REDDYS LABS SA | ANDA 078458 | AB1 | Dec 01, 2011 | |
| METHYLPHENIDATE HYDROCHLORIDE×2 | TRIS PHARMA INC | ANDA 091601 | AA | Jul 23, 2010 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ACTAVIS ELIZABETH | ANDA 040321 | — | Feb 05, 2002 | |
| METHYLPHENIDATE HYDROCHLORIDE | HERITAGE PHARMA | ANDA 075450 | — | Dec 21, 2001 | |
| METHYLPHENIDATE HYDROCHLORIDE | ABLE | ANDA 076032 | — | May 09, 2001 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | ABLE | ANDA 040404 | — | Mar 29, 2001 | |
| METHYLPHENIDATE HYDROCHLORIDE | WATSON LABS | ANDA 040410 | — | Feb 09, 2001 | |
| METHYLIN ER×2 | SPECGX LLC | ANDA 075629 | AB | May 09, 2000 | |
| METADATE ER | LANNETT CO INC | ANDA 040306 | — | Oct 20, 1999 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | SPECGX LLC | ANDA 040300 | AB | Nov 27, 1998 | |
| METHYLPHENIDATE HYDROCHLORIDE×3 | WATSON LABS | ANDA 040220 | — | Aug 29, 1997 | |
| METADATE ER | LANNETT CO INC | ANDA 089601 | — | Jun 01, 1988 | |
| METHYLPHENIDATE HYDROCHLORIDE | LANNETT CO INC | ANDA 086429 | — | Approved Prior to Jan 1, 1982 | |
| METHYLPHENIDATE HYDROCHLORIDE | LANNETT CO INC | ANDA 085799 | — | Approved Prior to Jan 1, 1982 | |
| METHYLPHENIDATE HYDROCHLORIDE | LANNETT CO INC | ANDA 086428 | — | Approved Prior to Jan 1, 1982 |
Listed patents (49)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8202537 | Mar 15, 2027 | in 9 mo | Product |
| 8062667 | Mar 29, 2029 | in 2 yr 10 mo | Product |
| 8465765 | Feb 15, 2031 | in 4 yr 9 mo | ProductU-1415 |
| 8778390 | Feb 15, 2031 | in 4 yr 9 mo | ProductU-1543 |
| 8956649 | Feb 15, 2031 | in 4 yr 9 mo | ProductU-1665 |
| 8563033 | Feb 15, 2031 | in 4 yr 9 mo | ProductU-1415 |
| 9040083 | Feb 15, 2031 | in 4 yr 9 mo | Product |
| 8287903 | Feb 15, 2031 | in 4 yr 9 mo | Product |
| 10292937 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 9603809 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 8916588 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 9028868 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 10617651 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 9034902 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 10881618 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 11911518 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 11241391 | Mar 23, 2032 | in 5 yr 10 mo | U-2357 |
| 11241392 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 9498447 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 9283214 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 9023389 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 10905652 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 8927010 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 10182995 | Mar 23, 2032 | in 5 yr 10 mo | Product |
| 9295642 | Aug 14, 2033 | in 7 yr 3 mo | ProductU-1827 |
| 11103495 | Aug 14, 2033 | in 7 yr 3 mo | ProductU-2993 |
| 9545399 | Aug 14, 2033 | in 7 yr 3 mo | ProductU-1827 |
| 9844544 | Aug 14, 2033 | in 7 yr 3 mo | ProductU-2203 |
| 10857143 | Aug 14, 2033 | in 7 yr 3 mo | ProductU-2993 |
| 11103494 | Aug 14, 2033 | in 7 yr 3 mo | Product |
| 8999386 | Aug 14, 2033 | in 7 yr 3 mo | Product |
| 11633389 | Aug 14, 2033 | in 7 yr 3 mo | Product |
| 10292939 | Oct 30, 2035 | in 9 yr 6 mo | ProductU-2357 |
| 10512613 | Oct 30, 2035 | in 9 yr 6 mo | U-2357 |
| 10449159 | Oct 30, 2035 | in 9 yr 6 mo | U-2357 |
| 10500162 | Oct 30, 2035 | in 9 yr 6 mo | U-2357 |
| 10568841 | Oct 30, 2035 | in 9 yr 6 mo | ProductU-2357 |
| 10111839 | Oct 30, 2035 | in 9 yr 6 mo | U-2357 |
| 10292938 | Oct 30, 2035 | in 9 yr 6 mo | Product |
| 10507186 | Oct 30, 2035 | in 9 yr 6 mo | Product |
| 10688060 | Oct 30, 2035 | in 9 yr 6 mo | Product |
| 10512612 | Oct 30, 2035 | in 9 yr 6 mo | Product |
| 9974752 | Oct 30, 2035 | in 9 yr 6 mo | Product |
| 10695336 | Feb 03, 2037 | in 10 yr 9 mo | U-4032 |
| 10265308 | Feb 03, 2037 | in 10 yr 9 mo | ProductU-4032 |
| 9855258 | Feb 03, 2037 | in 10 yr 9 mo | ProductU-4032 |
| 9827234 | Feb 03, 2037 | in 10 yr 9 mo | U-4032 |
| 9707217 | Feb 03, 2037 | in 10 yr 9 mo | Product |
| 10722473 | Nov 19, 2038 | in 12 yr 7 mo | U-2357 |
Methylphenidate hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

